Prevalence of HIV, hepatitis B, and hepatitis C infection in clinic patients
| VARIABLE | HIV INFECTION (ANTIBODY) | HEPATITIS B INFECTION (SURFACE ANTIGEN) | HEPATITIS C INFECTION (ANTIBODY) | ||||||
|---|---|---|---|---|---|---|---|---|---|
| NO. OF POSITIVE RESULTS (NO. OF AVAILABLE RESULTS) | PREVALENCE, % | P VALUE | NO. OF POSITIVE RESULTS (NO. OF AVAILABLE RESULTS) | PREVALENCE, % | P VALUE | NO. OF POSITIVE RESULTS (NO. OF AVAILABLE RESULTS) | PREVALENCE, % | P VALUE | |
| Total | 14 (657) | 2 | 32 (908) | 4 | 4 (886) | < 1 | |||
| Sex | .012 | .47 | .32 | ||||||
| • Male | 1 (259) | < 1 | 16 (389) | 4 | 3 (386) | < 1 | |||
| • Female | 13 (398) | 3 | 16 (519) | 3 | 1 (500) | < 1 | |||
| Age group, y | .70 | .10 | .54 | ||||||
| • 0–14 | 1 (94) | 1 | 2 (167) | 1 | 1 (158) | < 1 | |||
| • ≥ 15 | 13 (563) | 2 | 30 (741) | 4 | 3 (728) | < 1 | |||
| Region6 | < .001 | < .001 | .44 | ||||||
| • Africa | 13 (235) | 6 | 10 (320) | 3 | 1 (311) | < 1 | |||
| • Americas* | 0 (59) | 0 | 0 (69) | 0 | 0 (65) | 0 | |||
| • Asia† | 0 (89) | 0 | 16 (139) | 12 | 0 (136) | 0 | |||
| • Eastern Mediterranean | 1 (105) | < 1 | 3 (142) | 2 | 0 (141) | 0 | |||
| • Europe | 0 (169) | 0 | 3 (238) | 1 | 3 (233) | 1 | |||